讨论
产业链观察05-23 21:37
#药闻简讯# $Theriva Biologics(TOVX)$ VCN-01获得FDA快速通道认定，用于治疗转移性胰腺癌
简介：Theriva Biologics, Inc.成立于1986年，是一家生物技术公司，专注于合成DNA为基础的疗法和治疗严重疾病的创新型疾病缓解药物的发展。该公司是一家多元化的临床阶段公司，开发旨在治疗高度未满足需求领域疾病的疗法。公司通过收购VCN Biosciences，SL进入肿瘤学领域，VCN Biosciences，SL开发了一种新的溶瘤腺病毒平台，设计用于静脉、玻璃体内和抗肿瘤递送以触发肿瘤细胞死亡，改善共同给药的癌症疗法对肿瘤的获取，并促进患者免疫系统产生强大而持续的抗肿瘤反应。
| 今开：0.24 | 昨收：0.2475 |
| 最高：0.2594 | 最低：0.24 |
| 涨停价： | 跌停价： |
| 总市值：4232956 |
产业链观察05-23 21:37
#药闻简讯# $Theriva Biologics(TOVX)$ VCN-01获得FDA快速通道认定，用于治疗转移性胰腺癌
Theriva Biologics(TOVX)05-07 19:15
$Theriva Biologics(TOVX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001410578-24-000601 Act: 34 Size: 6 MB 网页链接
Theriva Biologics(TOVX)05-23 20:25
$Theriva Biologics(TOVX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-24-064544 Act: 34 Size: 240 KB 网页链接
Theriva Biologics(TOVX)05-16 19:35
$Theriva Biologics(TOVX)$ 8-K Current report, item 8.01 Accession Number: 0001104659-24-062270 Act: 34 Size: 196 KB 网页链接
Theriva Biologics(TOVX)04-16 20:05
$Theriva Biologics(TOVX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-24-047510 Act: 34 Size: 12 MB 网页链接
Theriva Biologics(TOVX)05-03 05:05
$Theriva Biologics(TOVX)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001104659-24-056462 Act: 33 Size: 1 MB 网页链接
Theriva Biologics(TOVX)03-25 19:45
$Theriva Biologics(TOVX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-038166 Act: 34 Size: 342 KB 网页链接
Theriva Biologics(TOVX)05-03 00:05
$Theriva Biologics(TOVX)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-24-056146 Act: 34 Size: 224 KB 网页链接
Theriva Biologics(TOVX)04-23 19:05
$Theriva Biologics(TOVX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-24-050307 Act: 34 Size: 247 KB 网页链接
Theriva Biologics(TOVX)03-26 04:25
$Theriva Biologics(TOVX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001410578-24-000293 Act: 34 Size: 12 MB 网页链接
价值本质05-28 22:28
$Theriva Biologics(TOVX)$ have lost 98% of my bet on this rubbish, with 100 in , only 2 left. Please cherish your life and money.查看全文
价值本质05-28 22:13
$Theriva Biologics(TOVX)$ please be careful, everyone查看全文
SeekingBiotech05-25 10:19
TOVX FDA Fast Track Designation Granted for VCN-01 for the Treatment of Metastatic Pancreatic Cancer$Theriva Biologics(TOVX)$
溶瘤病毒查看全文
产业链观察05-23 21:37
#药闻简讯# $Theriva Biologics(TOVX)$ VCN-01获得FDA快速通道认定，用于治疗转移性胰腺癌查看全文
不入流资讯2023-06-28 17:18
$Theriva Biologics(TOVX)$ Theriva Biologics soars 72% premarket after Co.'s VCN-01 secures FDA's orphan drug designation #AI_Mover#查看全文
Theriva Biologics(TOVX)盘前暴涨93%，报1.56美元。 Theriva Biologics今天宣布，美国美国食品药品监督管理局(FDA)已授予VCN-01孤儿药物指定，将用于治疗胰腺癌。在正在进行的多国2b期临床研究VIRAGE中，正在评估静脉注射VCN-01联合标准护理... 网页链接
$Theriva Biologics(TOVX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-24-064544 Act: 34 Size: 240 KB 网页链接
$Theriva Biologics(TOVX)$ 8-K Current report, item 8.01 Accession Number: 0001104659-24-062270 Act: 34 Size: 196 KB 网页链接
$Theriva Biologics(TOVX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-057689 Act: 34 Size: 310 KB 网页链接
$Theriva Biologics(TOVX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001410578-24-000601 Act: 34 Size: 6 MB 网页链接
$Theriva Biologics(TOVX)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001104659-24-056462 Act: 33 Size: 1 MB 网页链接
$Theriva Biologics(TOVX)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-24-056146 Act: 34 Size: 224 KB 网页链接
$Theriva Biologics(TOVX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-24-050307 Act: 34 Size: 247 KB 网页链接
$Theriva Biologics(TOVX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-24-050037 Act: 34 Size: 461 KB 网页链接
$Theriva Biologics(TOVX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-24-047510 Act: 34 Size: 12 MB 网页链接
$Theriva Biologics(TOVX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001410578-24-000293 Act: 34 Size: 12 MB 网页链接